Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Mar;77(6):917–925. doi: 10.1038/bjc.1998.152

Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.

R Palmqvist 1, A Oberg 1, C Bergström 1, J N Rutegård 1, B Zackrisson 1, R Stenling 1
PMCID: PMC2150107  PMID: 9528835

Abstract

The prognosis of colorectal cancer has not significantly changed during the last 30 years. While evaluation of tumour cell proliferation may provide prognostic information, results obtained so far have been contradictory Heterogeneity in tumour cell proliferation may explain these contradictions. With in vivo injection of iododeoxyuridine (IdUrd), estimation of labelling index (LI), S-phase transit time (Ts) and potential doubling time (Tpot) may be performed from a single sample. A total of 109 colorectal cancers were studied after in vivo injection of IdUrd before surgical removal. From each cancer, four to eight samples were processed for both flow cytometrical (FCM) and immunohistochemical (IHC) visualization of IdUrd incorporation. LI/IHC was morphometrically quantified at both the luminal border and the invasive margin of these tumours. LI was significantly higher at the luminal border compared with the invasive margin, although they were correlated with each other. Using combined IHC and FCM methods, rapidly growing colorectal cancers (high LI and/or low Tpot) showed an increased survival (significant for LI at the invasive margin and for Tpot at both the invasive margin and the luminal border) in the entire unselected material and for radically removed Dukes' B tumours. FCM data alone did not discriminate for survival, with the exception of Ts in diploid and radically removed Dukes' B tumours.

Full text

PDF
920

Images in this article

918Figure 1
on p.918
919Figure 2
on p.919
920Figure 4
on p.920

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baretton G. B., Diebold J., Christoforis G., Vogt M., Müller C., Dopfer K., Schneiderbanger K., Schmidt M., Löhrs U. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer. 1996 Jan 15;77(2):255–264. doi: 10.1002/(SICI)1097-0142(19960115)77:2<255::AID-CNCR6>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  2. Bauer K. D., Bagwell C. B., Giaretti W., Melamed M., Zarbo R. J., Witzig T. E., Rabinovitch P. S. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry. 1993;14(5):486–491. doi: 10.1002/cyto.990140506. [DOI] [PubMed] [Google Scholar]
  3. Bauer K. D., Lincoln S. T., Vera-Roman J. M., Wallemark C. B., Chmiel J. S., Madurski M. L., Murad T., Scarpelli D. G. Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinomas. Lab Invest. 1987 Sep;57(3):329–335. [PubMed] [Google Scholar]
  4. Begg A. C., McNally N. J., Shrieve D. C., Kärcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry. 1985 Nov;6(6):620–626. doi: 10.1002/cyto.990060618. [DOI] [PubMed] [Google Scholar]
  5. Bennett M. H., Wilson G. D., Dische S., Saunders M. I., Martindale C. A., Robinson B. M., O'Halloran A. E., Leslie M. D., Laing J. H. Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer. 1992 Jun;65(6):870–878. doi: 10.1038/bjc.1992.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dische S., Saunders M. I. Continuous, hyperfractionated, accelerated radiotherapy (CHART). Br J Cancer. 1989 Mar;59(3):325–326. doi: 10.1038/bjc.1989.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Enker W. E., Kimmel M., Cibas E. S., Cranor M. L., Melamed M. R. DNA/RNA content and proliferative fractions of colorectal carcinomas: a five-year prospective study relating flow cytometry to survival. J Natl Cancer Inst. 1991 May 15;83(10):701–707. doi: 10.1093/jnci/83.10.701. [DOI] [PubMed] [Google Scholar]
  8. Gamel J. W., Meyer J. S., Province M. A. Proliferative rate by S-phase measurement may affect cure of breast carcinoma. Cancer. 1995 Sep 15;76(6):1009–1018. doi: 10.1002/1097-0142(19950915)76:6<1009::aid-cncr2820760615>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  9. Gundersen H. J., Bendtsen T. F., Korbo L., Marcussen N., Møller A., Nielsen K., Nyengaard J. R., Pakkenberg B., Sørensen F. B., Vesterby A. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS. 1988 May;96(5):379–394. doi: 10.1111/j.1699-0463.1988.tb05320.x. [DOI] [PubMed] [Google Scholar]
  10. Gundersen H. J., Jensen E. B. The efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987 Sep;147(Pt 3):229–263. doi: 10.1111/j.1365-2818.1987.tb02837.x. [DOI] [PubMed] [Google Scholar]
  11. Gundersen H. J., Osterby R. Optimizing sampling efficiency of stereological studies in biology: or 'do more less well!'. J Microsc. 1981 Jan;121(Pt 1):65–73. doi: 10.1111/j.1365-2818.1981.tb01199.x. [DOI] [PubMed] [Google Scholar]
  12. Harlow S. P., Eriksen B. L., Poggensee L., Chmiel J. S., Scarpelli D. G., Murad T., Bauer K. D. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas. Cancer Res. 1991 May 1;51(9):2403–2409. [PubMed] [Google Scholar]
  13. Hiddemann W., Von Bassewitz D. B., Kleinemeier H. J., Schulte-Brochterbeck E., Hauss J., Lingemann B., Büchner T., Grundmann E. DNA stemline heterogeneity in colorectal cancer. Cancer. 1986 Jul 15;58(2):258–263. doi: 10.1002/1097-0142(19860715)58:2<258::aid-cncr2820580210>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  14. Holm T., Cedermark B., Rutqvist L. E. Local recurrence of rectal adenocarcinoma after 'curative' surgery with and without preoperative radiotherapy. Br J Surg. 1994 Mar;81(3):452–455. doi: 10.1002/bjs.1800810344. [DOI] [PubMed] [Google Scholar]
  15. Jass J. R., Atkin W. S., Cuzick J., Bussey H. J., Morson B. C., Northover J. M., Todd I. P. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology. 1986 May;10(5):437–459. doi: 10.1111/j.1365-2559.1986.tb02497.x. [DOI] [PubMed] [Google Scholar]
  16. Koha M., Caspersson T. O., Wikström B., Brismar B. Heterogeneity of DNA distribution pattern in colorectal carcinoma. A microspectrophotometric study of fine needle aspirates. Anal Quant Cytol Histol. 1990 Oct;12(5):348–351. [PubMed] [Google Scholar]
  17. Koochekpour S., Merzak A., Pilkington G. J. Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma cell lines. Eur J Cancer. 1995;31A(3):375–380. doi: 10.1016/0959-8049(94)00476-l. [DOI] [PubMed] [Google Scholar]
  18. Kubota Y., Petras R. E., Easley K. A., Bauer T. W., Tubbs R. R., Fazio V. W. Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer. 1992 Dec 1;70(11):2602–2609. doi: 10.1002/1097-0142(19921201)70:11<2602::aid-cncr2820701106>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  19. Larsson P., Roos G., Stenling R., Ljungberg B. Proliferation of human renal cell carcinoma studied with in vivo iododeoxyuridine labelling and immunohistochemistry. Scand J Urol Nephrol. 1994 Jun;28(2):135–140. doi: 10.3109/00365599409180489. [DOI] [PubMed] [Google Scholar]
  20. Lawrence D. A. Transforming growth factor-beta: a general review. Eur Cytokine Netw. 1996 Sep;7(3):363–374. [PubMed] [Google Scholar]
  21. Lindmark G., Glimelius B., Påhlman L., Enblad P. Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas. Int J Colorectal Dis. 1991 May;6(2):115–120. doi: 10.1007/BF00300207. [DOI] [PubMed] [Google Scholar]
  22. Lochrin C. A., Wilson G. D., McNally N. J., Dische S., Saunders M. I. Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report. Int J Radiat Oncol Biol Phys. 1992;24(1):87–91. doi: 10.1016/0360-3016(92)91026-j. [DOI] [PubMed] [Google Scholar]
  23. MacFarlane J. K., Ryall R. D., Heald R. J. Mesorectal excision for rectal cancer. Lancet. 1993 Feb 20;341(8843):457–460. doi: 10.1016/0140-6736(93)90207-w. [DOI] [PubMed] [Google Scholar]
  24. Moertel C. G., Fleming T. R., Macdonald J. S., Haller D. G., Laurie J. A., Tangen C. M., Ungerleider J. S., Emerson W. A., Tormey D. C., Glick J. H. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med. 1995 Mar 1;122(5):321–326. doi: 10.7326/0003-4819-122-5-199503010-00001. [DOI] [PubMed] [Google Scholar]
  25. Mullan F. J., Wilson H. K., Majury C. W., Mills J. O., Cromie A. J., Campbell G. R., McKelvey S. T. Bile acids and the increased risk of colorectal tumours after truncal vagotomy. Br J Surg. 1990 Oct;77(10):1085–1090. doi: 10.1002/bjs.1800771004. [DOI] [PubMed] [Google Scholar]
  26. Nylander K., Anneroth G., Gustafsson H., Roos G., Stenling R., Zackrisson B. Cell kinetics of head and neck squamous cell carcinomas. Prognostic implications. Acta Oncol. 1994;33(1):23–28. doi: 10.3109/02841869409098370. [DOI] [PubMed] [Google Scholar]
  27. Paradiso A., Rabinovich M., Vallejo C., Machiavelli M., Romero A., Perez J., Lacava J., Cuevas M. A., Rodriquez R., Leone B. p53 and PCNA expression in advanced colorectal cancer: response to chemotherapy and long-term prognosis. Int J Cancer. 1996 Dec 20;69(6):437–441. doi: 10.1002/(SICI)1097-0215(19961220)69:6<437::AID-IJC2>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  28. Pilkington G. J. Glioma heterogeneity in vitro: the significance of growth factors and gangliosides. Neuropathol Appl Neurobiol. 1992 Oct;18(5):434–442. doi: 10.1111/j.1365-2990.1992.tb00809.x. [DOI] [PubMed] [Google Scholar]
  29. Quirke P., Dyson J. E., Dixon M. F., Bird C. C., Joslin C. A. Heterogeneity of colorectal adenocarcinomas evaluated by flow cytometry and histopathology. Br J Cancer. 1985 Jan;51(1):99–106. doi: 10.1038/bjc.1985.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rew D. A. Cell proliferation, tumour growth and clinical outcome: gains and losses in intestinal cancer. Ann R Coll Surg Engl. 1993 Nov;75(6):397–404. [PMC free article] [PubMed] [Google Scholar]
  31. Rew D. A., Wilson G. D., Taylor I., Weaver P. C. Proliferation characteristics of human colorectal carcinomas measured in vivo. Br J Surg. 1991 Jan;78(1):60–66. doi: 10.1002/bjs.1800780120. [DOI] [PubMed] [Google Scholar]
  32. Riccardi A., Giordano M., Danova M., Girino M., Brugnatelli S., Ucci G., Mazzini G. Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non-lymphoblastic leukaemia. Eur J Cancer. 1991;27(7):882–887. doi: 10.1016/0277-5379(91)90139-5. [DOI] [PubMed] [Google Scholar]
  33. Riethmüller G., Schneider-Gädicke E., Schlimok G., Schmiegel W., Raab R., Höffken K., Gruber R., Pichlmaier H., Hirche H., Pichlmayr R. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet. 1994 May 14;343(8907):1177–1183. doi: 10.1016/s0140-6736(94)92398-1. [DOI] [PubMed] [Google Scholar]
  34. Scott N. A., Grande J. P., Weiland L. H., Pemberton J. H., Beart R. W., Jr, Lieber M. M. Flow cytometric DNA patterns from colorectal cancers--how reproducible are they? Mayo Clin Proc. 1987 May;62(5):331–337. doi: 10.1016/s0025-6196(12)65435-4. [DOI] [PubMed] [Google Scholar]
  35. Shepherd N. A., Richman P. I., England J. Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations. J Pathol. 1988 Jul;155(3):213–219. doi: 10.1002/path.1711550306. [DOI] [PubMed] [Google Scholar]
  36. Taniyama K., Sasaki N., Wada S., Sasaki M., Miyoshi N., Nakai H., Kodama S., Nakatsuka H., Tahara E. Comparison of proliferative activities and metastases between two subtypes classified at the deeply infiltrating sites of colorectal moderately differentiated adenocarcinomas. Pathol Int. 1996 Mar;46(3):195–203. doi: 10.1111/j.1440-1827.1996.tb03598.x. [DOI] [PubMed] [Google Scholar]
  37. Taniyama K., Suzuki H., Matsumoto M., Hakamada K., Toyama K., Tahara E. Relationships between nodal status and cell kinetics, DNA ploidy pattern and histopathology of the deeply infiltrating sites in colorectal adenocarcinoma. Acta Pathol Jpn. 1993 Oct;43(10):590–596. doi: 10.1111/j.1440-1827.1993.tb03235.x. [DOI] [PubMed] [Google Scholar]
  38. Teixeira C. R., Tanaka S., Haruma K., Yoshihara M., Sumii K., Kajiyama G. Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer. 1994 Feb 1;73(3):575–579. doi: 10.1002/1097-0142(19940201)73:3<575::aid-cncr2820730313>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  39. Terry N. H., Meistrich M. L., Roubein L. D., Lynch P. M., Dubrow R. A., Rich T. A. Cellular kinetics in rectal cancer. Br J Cancer. 1995 Aug;72(2):435–441. doi: 10.1038/bjc.1995.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Thorgeirsson U. P., Turpeenniemi-Hujanen T., Neckers L. M., Johnson D. W., Liotta L. A. Protein synthesis but not DNA synthesis is required for tumor cell invasion in vitro. Invasion Metastasis. 1984;4(2):73–83. [PubMed] [Google Scholar]
  41. Vermeulen P. B., Verhoeven D., Hubens G., Van Marck E., Goovaerts G., Huyghe M., De Bruijn E. A., Van Oosterom A. T., Dirix L. Y. Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas. Ann Oncol. 1995 Jan;6(1):59–64. doi: 10.1093/oxfordjournals.annonc.a059043. [DOI] [PubMed] [Google Scholar]
  42. Wilson G. D. Assessment of human tumour proliferation using bromodeoxyuridine--current status. Acta Oncol. 1991;30(8):903–910. doi: 10.3109/02841869109088242. [DOI] [PubMed] [Google Scholar]
  43. Wilson M. S., West C. M., Wilson G. D., Roberts S. A., James R. D., Schofield P. F. An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers. Br J Cancer. 1993 Apr;67(4):754–759. doi: 10.1038/bjc.1993.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wilson M. S., West C. M., Wilson G. D., Roberts S. A., James R. D., Schofield P. F. Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer. Br J Cancer. 1993 Sep;68(3):501–506. doi: 10.1038/bjc.1993.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Witzig T. E., Loprinzi C. L., Gonchoroff N. J., Reiman H. M., Cha S. S., Wieand H. S., Katzmann J. A., Paulsen J. K., Moertel C. G. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer. 1991 Aug 15;68(4):879–888. doi: 10.1002/1097-0142(19910815)68:4<879::aid-cncr2820680434>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  46. al-Sheneber I. F., Shibata H. R., Sampalis J., Jothy S. Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer. 1993 Mar 15;71(6):1954–1959. doi: 10.1002/1097-0142(19930315)71:6<1954::aid-cncr2820710605>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES